Novavax, Inc. (NVAX)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-Market:
| Previous Close | 4.4700 |
| Open | 4.4800 |
| Bid | 4.4300 x 400 |
| Ask | 4.5000 x 400 |
| Day's Range | 4.4300 - 4.5550 |
| 52 Week Range | 3.5300 - 10.3000 |
| Volume | |
| Avg. Volume | 6,825,290 |
| Market Cap | 627.601M |
| Beta (5Y Monthly) | 1.62 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Yahoo Finance UK
Trending tickers: TSMC, Novavax, Anglo American and IAG
The latest investor updates on stocks that are trending on Friday
- Barrons.com
These Stocks Are Moving the Most Today: Novavax, Akamai, Taiwan Semi, SoundHound, JFrog, Dropbox, Yelp, and More
Novavax signs a $1.2 billion licensing deal with France’s Sanofi, guidance from Akamai Technologies misses estimates, and SoundHound stock surges after first-quarter revenue jumps 73%.
- Reuters
Novavax erases doubts about its ability to remain in business
In February last year, Novavax had raised doubts about its ability to remain in business and announced plans to slash spending as it worked to prepare for a fall vaccination campaign. The company also said on Friday that its revenue rose to $94 million in the first quarter, from $81 million in the same period in 2023.
© 2024 Yahoo. All rights reserved.